Adoptive Cellular Immunotherapy in Glioblastoma: Mechanistic Insights, Clinical Progress, and Future Directions of CAR-T and TIL Therapies
Alper DEMIREZEN & Gizem Nur Mutlu · Asian Journal of Medical Principles and Clinical Practice · 2026
Glioblastoma remains the most common and lethal primary malignant brain tumour in adults, and outcomes have changed little despite maximal surgical resection, radiotherapy and temozolomide chemotherapy. Adoptive cellular immunotherapy, principally chimeric antigen receptor T-cell...
Open access
Research Article
10.9734/ajmpcp/2026/v9i2464